The Beauty Health Company, home to flagship brand Hydrafacial, has announced its financial results for Q3 2025. While device sales remained under pressure, the recurring consumables business continued to demonstrate resilience and profitability.
Three Months and Nine Months Revenue Decrease, Adjusted EBITDA Increase
For the three months ended September 30, 2025, revenue totaled $70.7 million (compared to $78.8 million in 2024), a decrease of 10.3% due to lower delivery systems and consumables net sales. For the nine months, revenue totaled $218.4 million (compared to $250.8 million in 2024).
For the three months, adjusted EBITDA hit $8.9 million (compared to $8.1 million in 2024) while nine months saw $30.1 million (compared to $3.2 million in 2024). The improvement in adjusted EBITDA was primarily due to lower operational spend, partially offset by lower adjusted gross profit.
The company had approximately 7 million private placement warrants and approximately 127 million shares of Class A common stock outstanding. Cash, cash equivalents and restricted cash were approximately $219 million as of September 30, 2025, compared to approximately $370 million as of December 31, 2024.
